Silvana De Pirro

Silvana De Pirro

Auto-generated profile, based on publicly available information

Silvana De Pirro

Department of Physiology and Pharmacology “V. Erspamer” Sapienza University of Rome Rome Italy

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
ABAldo Badiani
Aldo Badiani
JBJoseph M. Boden
Joseph M. Boden
SPSilvana De Pirro
Silvana De Pirro
DFDavid M. Fergusson
David M. Fergusson
LHL. John Horwood
L. John Horwood
GHGordon T. Harold
Gordon T. Harold

8 April 2023 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
MMMichele Stanislaw Milella
Michele Stanislaw Milella
GDGinevra D'Ottavio
Ginevra D'Ottavio
SPSilvana De Pirro
Silvana De Pirro
MBMassimo Barra
Massimo Barra
DCDaniele Caprioli
Daniele Caprioli
ABAldo Badiani
Aldo Badiani
Heroin is an opioid agonist commonly abused for its rewarding effects. Since its synthesis at the end of the nineteenth century, its popularity as a recreational drug has ebbed and flowed. In the last three decades, heroin use has increased again, and yet the pharmacology of heroin is still poorly understood. After entering the body, heroin is rapidly deacetylated to 6-monoacetylmorphine (6-MAM), which is then deacetylated to morphine. Thus, drug addiction literature has long settled on the notion that heroin is little more than a pro-drug. In contrast to these former views, we will argue for a more complex interplay among heroin and its active metabolites: 6-MAM, morphine, and morphine-6-glucuronide (M6G). In particular, we propose that the complex temporal pattern of heroin effects results from the sequential, only partially overlapping, actions not only of 6-MAM, morphine, and M6G, but also of heroin per se, which, therefore, should not be seen as a mere brain-delivery system for its active metabolites. We will first review the literature concerning the pharmacokinetics and pharmacodynamics of heroin and its metabolites, then examine their neural and behavioral effects, and finally discuss the possible implications of these data for a better understanding of opioid reward and heroin addiction. By so doing we hope to highlight research topics to be investigated by future clinical and pre-clinical studies.

14 May 2018 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
SPSilvana De Pirro
Silvana De Pirro
GGGaspare Galati
Gaspare Galati
LPLuigi Pizzamiglio
Luigi Pizzamiglio
ABAldo Badiani
Aldo Badiani
Previous studies have shown that individuals with heroin and cocaine addiction prefer to use these drugs in distinct settings: mostly at home in the case of heroin and mostly outside the home in the case of cocaine. Here we investigated whether the context would modulate the affective and neural responses to these drugs in a similar way. First, we used a novel emotional task to assess the affective state produced by heroin or cocaine in different settings, based on the recollections of male and female drug users. Then we used fMRI to monitor neural activity during drug imagery (re-creating the setting of drug use) in male drug users. Consistent with our working hypothesis, the majority of participants reported a shift in the affective valence of heroin from mostly pleasant at home to mostly unpleasant outside the home (p< 0.0001). The opposite shift was observed for cocaine; that is, most participants who found cocaine pleasant outside the home found it unpleasant when taken at home (p< 0.0014). Furthermore, we found a double dissociation, as a function of drug and setting imagery, in BOLD signal changes in the left PFC and caudate, and bilaterally in the cerebellum (allpvalues <0.01), suggesting that the fronto-striatal-cerebellar network is implicated in the contextualization of drug-induced affect. In summary, we report that the same setting can influence in opposite directions the affective and neural response to psychostimulants versus opiates in humans, adding to growing evidence of distinct substrates for the rewarding effects of these two drug classes.SIGNIFICANCE STATEMENTThe rewarding effects of addictive drugs are often thought to depend on shared substrates. Yet, environmental influences can unmask striking differences between psychostimulants and opiates. Here we used emotional tasks and fMRI to explore the influence of setting on the response to heroin versus cocaine in individuals with addiction. Simply moving from one setting to another significantly decreased heroin pleasure but increased cocaine pleasure, and vice versa. Similar double dissociation was observed in the activity of the fronto-striatal-cerebellar network. These findings suggest that the effects of opiates and psychostimulants depend on dissociable psychological and neural substrates and that therapeutic approaches to addiction should take into account the peculiarities of different drug classes and the settings of drug use.

27 March 2025 in British Journal of Pharmacology
Verified
Journal Article
Open access
GDGinevra D'Ottavio
Ginevra D'Ottavio
SPSara Pezza
Sara Pezza
JMJacopo Modoni
Jacopo Modoni
IRIngrid Reverte
Ingrid Reverte
CMClaudia Marchetti
Claudia Marchetti
DCDaniele Caprioli
Daniele Caprioli
Background and Purpose: Heroin and cocaine users tailor their dosage, frequency and administration route to maximise the drugs' effects or prevent withdrawal symptoms. Counterintuitively, preclinical self‐administration and choice experiments employ, almost invariably and regardless of the pharmacokinetic properties of the drug under examination, fixed unit‐doses and timeouts (after unit‐doses) largely resulting in uniform drug‐taking patterns. This uniformity contrasts with the large variability observed in humans, which serves as critical indicator of addiction severity and treatment success. Here, by combining behavioural and pharmacokinetics assessments, we revealed that drug self‐administration procedures without timeouts may overcome this limitation.Experimental Approach: We analysed heroin‐ and cocaine‐taking patterns and seeking and estimated drug‐brain levels in the presence or absence of timeout under different training conditions.Key Results: Removing timeouts had a profound effect on heroin‐taking patterns and seeking, promoting the emergence of burst‐like intake, yielding higher brain peak concentrations of heroin. In contrast, the removal of timeout had marginal impact on cocaine‐taking patterns and seeking.Conclusion and Implications: The removal of timeout during self‐administration revealed distinct cocaine and heroin patterns, with the latter closely resembling human heroin use patterns.

20 June 2019 in Addiction Biology
Verified
Journal Article
Closed access
PDF file
SPSilvana De Pirro
Silvana De Pirro
PLPeter Lush
Peter Lush
JPJim Parkinson
Jim Parkinson
TDTheodora Duka
Theodora Duka
HCHugo D. Critchley
Hugo D. Critchley
ABAldo Badiani
Aldo Badiani

23 September 2024 in Substance use & addiction journal
Verified
Journal Article
Closed access
FMFrancesca Melis
Francesca Melis
TCThomas Clausen
Thomas Clausen
CCCharlotte Castel
Charlotte Castel
Omid DadrasOmid Dadras
Omid Dadras
SPSilvana De Pirro
Silvana De Pirro
DEDesiree Eide
Desiree Eide
Background: Heroin-assisted treatment (HAT) is an evidence-based treatment option for opioid use disorder (OUD), available in a limited number of countries. Norway implemented a 5-year HAT project in 2022, aiming to assess its effectiveness and its potential integration into the country’s OUD treatment system. This study describes and compares patients’ baseline characteristics from the Oslo and Bergen HAT clinics, providing a comprehensive picture of the unique population and the real-world application of HAT. Methods: This cross-sectional study examines the baseline characteristics of consenting HAT patients within the first 2 years of operation ( n = 86). Self-reported questionnaires gathered sociodemographics, previous treatment experiences, self-reported crime, and substance use, as well as motivations and expectations for treatment. Comparisons between the clinics were carried out using t -tests, Mann–Whitney U tests, Chi-square, and Fisher’s exact test. Results: The majority of the patients were enrolled at the Oslo clinic (76%) and were male (80%). At admission, the average age was 45.9, with a significantly younger group in Bergen (42.5 vs 47.3, P < .05). While no patients reported being unhoused, 17% noted unstable housing within the preceding month. Unemployment was prevalent (91%) alongside previous treatment experiences (95%), with a median of 2 prior medication types. In the 3 months preceding HAT initiation, 78% of patients reported being victims of crime, and 44% committed at least one crime. Over their lifetime, 2 in 5 participants (41%) had experienced an unwanted overdose and 43% had shared syringes and equipment. Conclusion: This study reveals a cohort experiencing societal marginalization, including unstable housing, unsatisfactory prior OUD treatment, high-risk behaviors, and frequent interactions with criminal activities, predominantly as victims. While the Oslo and Bergen clinics serve a similar patient profile, notable differences emerged in the reasons for discontinuing past OUD treatment and crime-related factors.